58 related articles for article (PubMed ID: 33459893)
1. The European Reference Network for Rare Neurological Diseases.
Reinhard C; Bachoud-Lévi AC; Bäumer T; Bertini E; Brunelle A; Buizer AI; Federico A; Gasser T; Groeschel S; Hermanns S; Klockgether T; Krägeloh-Mann I; Landwehrmeyer GB; Leber I; Macaya A; Mariotti C; Meissner WG; Molnar MJ; Nonnekes J; Ortigoza Escobar JD; Pérez Dueñas B; Renna Linton L; Schöls L; Schuele R; Tijssen MAJ; Vandenberghe R; Volkmer A; Wolf NI; Graessner H
Front Neurol; 2020; 11():616569. PubMed ID: 33519696
[TBL] [Abstract][Full Text] [Related]
2. A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.
Ha N; Choi YI; Jung N; Song JY; Bae DK; Kim MC; Lee YJ; Song H; Kwak G; Jeong S; Park S; Nam SH; Jung SC; Choi BO
Br J Pharmacol; 2020 Nov; 177(22):5096-5113. PubMed ID: 33460073
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-Function Properties of a Dynamin 2 Mutant Implicated in Charcot-Marie-Tooth Disease.
Tassin TC; Barylko B; Hedde PN; Chen Y; Binns DD; James NG; Mueller JD; Jameson DM; Taussig R; Albanesi JP
Front Cell Neurosci; 2021; 15():745940. PubMed ID: 34744632
[TBL] [Abstract][Full Text] [Related]
4. Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.
Zhao M; Maani N; Dowling JJ
Neurotherapeutics; 2018 Oct; 15(4):966-975. PubMed ID: 30426359
[TBL] [Abstract][Full Text] [Related]
5. A new mutation in DNM2 gene in a large Italian family.
Lopergolo D; Bocci S; Pinto AM; Valentino F; Doddato G; Ginanneschi F; Volpi N; Renieri A; Giannini F
Neurol Sci; 2021 Jun; 42(6):2509-2513. PubMed ID: 33459893
[TBL] [Abstract][Full Text] [Related]
6. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
7. Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.
Chen S; Huang P; Qiu Y; Zhou Q; Li X; Zhu M; Hong D
Neuropathology; 2018 Feb; 38(1):34-40. PubMed ID: 28971531
[TBL] [Abstract][Full Text] [Related]
8. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease.
Fabrizi GM; Ferrarini M; Cavallaro T; Cabrini I; Cerini R; Bertolasi L; Rizzuto N
Neurology; 2007 Jul; 69(3):291-5. PubMed ID: 17636067
[TBL] [Abstract][Full Text] [Related]
9. Mice carrying an analogous heterozygous dynamin 2 K562E mutation that causes neuropathy in humans develop predominant characteristics of a primary myopathy.
Pereira JA; Gerber J; Ghidinelli M; Gerber D; Tortola L; Ommer A; Bachofner S; Santarella F; Tinelli E; Lin S; Rüegg MA; Kopf M; Toyka KV; Suter U
Hum Mol Genet; 2020 May; 29(8):1253-1273. PubMed ID: 32129442
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variability in a large Czech family with a dynamin 2-associated Charcot-Marie-Tooth neuropathy.
Haberlová J; Mazanec R; Ridzoň P; Baránková L; Nürnberg G; Nürnberg P; Sticht H; Huehne K; Seeman P; Rautenstrauss B
J Neurogenet; 2011 Dec; 25(4):182-8. PubMed ID: 22091729
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.
Cortese A; Wilcox JE; Polke JM; Poh R; Skorupinska M; Rossor AM; Laura M; Tomaselli PJ; Houlden H; Shy ME; Reilly MM
Neurology; 2020 Jan; 94(1):e51-e61. PubMed ID: 31827005
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
